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Abstract
Background: Lumbar spinal stenosis (LSS) causing neurogenic claudication is a leading cause of pain, disability and
loss of independence in older adults. The prevalence of lumbar spinal stenosis is growing rapidly due to an aging
population. The dominant limitation in LSS is walking ability. Postural, physical and psychosocial factors can impact
symptoms and functional ability. LSS is the most common reason for spine surgery in older adults yet the vast
majority of people with LSS receive non-surgical treatment. What constitutes effective non-surgical treatment is
unknown. The purpose of this study is to evaluate the effectiveness of a multi-modal and self-management training
program, known as the Boot Camp Program for LSS aimed at improving walking ability and other relevant
patient-centred outcomes.
Methods: We will use a pragmatic two-arm randomized controlled single blinded (assessor) study design.
Eligible and consenting participants will be randomized to receive from licensed chiropractors either a 6-week
(twice weekly) self-management training program (manual therapy, education, home exercises) with an
instructional workbook and video and a pedometer or a single instructional session with an instructional workbook
and video and pedometer. The main outcome measure will be the self-paced walking test measured at 6 months.
We will also assess outcomes at 8 weeks and 3 and 12 months.
Discussion: Symptoms and functional limitations in LSS are variable and influenced by changes in spinal
alignment. Physical and psychological factors result in chronic disability for patients with LSS.
The Boot Camp Program is a 6-week self-management training program aimed at the multi-faceted aspects
of LSS and trains individuals to use self-management strategies. The goal is to provide life-long self-management
strategies that maximize walking and overall functional abilities and quality of life.
Trial registration: ClinicalTrials.gov ID: NCT02592642.
Keywords: Lumbar spinal stenosis, Neurogenic claudication, Self-management, Walking, Randomized
controlled trial, Boot camp program, Multi-modal treatment, Non-surgical
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Background
Lumbar spinal stenosis (LSS) refers to an anatomical
narrowing of the central and/or lateral spinal canals [1].
It is usually caused by age related degenerative changes
in the spine including intervertebral disc thinning, facet
joint thickening and in-folding of the ligamentum flavum
[2]. These changes contribute to a decrease in cross-
sectional area of the spinal canal that can lead to compres-
sion and diminished blood flow to the spinal nerves [3, 4].
The clinical syndrome caused by LSS is known as neuro-
genic claudication. This syndrome is characterized by bilat-
eral or unilateral buttock, lower extremity pain, heaviness,
numbness, tingling or weakness, precipitated by walking
and standing and [5] relieved by sitting and bending
forward [2, 6]. Neurogenic claudication due to LSS is a
leading cause of pain, disability and loss of independence in
people over the age of 65 [7]. Limited walking ability is the
dominant functional impairment caused by LSS [2]. Those
afflicted have greater walking limitations than individuals
with knee or hip osteoarthritis [8] and greater functional
limitations than those with congestive heart failure, chronic
obstructive lung disease or systemic lupus erythematosus
[7]. Inability to walk among individuals with LSS leads to a
sedentary lifestyle and a progressive decline in health status
[9, 10]. Furthermore, symptomatic LSS is also associated
with increased levels of depression; anxiety and hopeless-
ness that can further perpetuate disability [11–14].
The prevalence and economic burden of LSS is growing
exponentially due to the aging population. In Japan where
25 % of the population is over the age of 65, about 12
million people suffer from symptomatic LSS [15]. A similar
epidemic is expected in the US by the year 2030 when an
estimated 73 million people will be over the age of 65 [16]
of which 30 % are projected to have symptomatic LSS [17].
LSS is the most common reason for spine surgery in
individuals over the age of 65 [18], however only very few
patients receive surgery [19]. The vast majority of individ-
uals with LSS receive non-surgical care. However, what
constitutes effective non-surgical care is unknown [20–23].
We have designed and implemented a training program
for LSS known as the Boot Camp Program for LSS [24].
This program aims to address the multi-faceted aspects of
LSS using a multi-modal non-surgical approach with a
focus on self-management and the goals of improved walk-
ing ability, overall functional status and quality of life. The
program considers the dynamic nature of LSS where symp-
toms change relative to posture. Reduction of the lumbar
lordosis while standing, walking and sitting reduces
epidural pressure and improves blood flows to spinal nerves
[3, 11]. Enabling patients to introduce inter-segmental
lumbar spine flexion (reducing the lumbar lordosis) using
anterior pelvic tilt may reduce symptoms and improve
walking ability [25–27]. Individuals with LSS tend to be
deconditioned due to inability to walk and consequential
sedentary lifestyle and may not have the necessary core
strength and lumbar flexibility to accomplish this body
realignment. They can also have reduced lower extremity
strength due to combined nerve root compression and
disuse. Specific flexibility, aerobic and core and lower
extremity strengthening exercises, manual therapy and
postural instruction may overcome these deficiencies.
The program also considers potential psychosocial con-
sequences of LSS and incorporates a cognitive behavioral
approach [28, 29]. This approach aims to improve coping
and problem solving, build self-efficacy, provide feedback
and develop realistic treatment and functional goals. Since
LSS is a chronic and often-progressive condition [30] the
program emphasizes incorporating learned physical and
psychosocial self-management strategies for life. Patients
receive an instructional workbook and video as part of the
training program. The workbook and video provide
education on self-management strategies and instruction
on how to perform all the specific exercises and body
realignment techniques. The workbook incorporates a
schedule outlining the intensity and frequency of each
exercise with goals tailored to each patient. The training
program also includes a pedometer that provides weekly
feedback for both patients and practitioners on walking
ability.
In a previous retrospective study we evaluated 49
consecutive patients who completed the Boot Camp Pro-
gram and assessed the difference in self-report outcomes
selected a priori [24]. Outcome measures included the
Oswestry Low Back Pain Disability Index, the walking score
of the Oswestry Low Back Pain Disability Index, the three
subscales of the Zurich Swiss Spinal Questionnaire, and the
Numeric Rating Scale for leg and back pain. Following the
6-week intervention there were both statistically and clinic-
ally important improvements in all outcomes from baseline.
This was a before and after study without a control group
and therefore provided low quality preliminary evidence on
the effectiveness of the program.
The purpose of this study is to assess the effectiveness
of the Boot Camp Program in improving outcomes using
a randomized controlled trial (RCT) design. Our main
objective is to compare the effectiveness of a comprehen-
sive 6-week self-management training program that
includes a patient instructional workbook, video and ped-
ometer to a single training session with provision of a
patient workbook, video and pedometer. We hypothesize
that the self-management training program will be more
effective in improving walking capacity and functional
outcomes than a single training session.
Methods
Design
We will conduct a pragmatic two arm single blinded
(assessor) RCT (Fig. 1).
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Source population
Eligible participants are individuals who consult with
specialists (orthopedists, neurosurgeons, rheumatologists,
neurologists or physiatrists), family physicians or chiro-
practors for symptoms suggestive of neurogenic claudica-
tion at one of seven hospitals and several community
clinics in Toronto, Canada and the surrounding area.
Recruitment
Participating physicians and chiropractors will identify
potential participants using an eligibility checklist (Table 1).
Eligible potential participants will be given a pamphlet
outlining information concerning the study and providing
contact information for the trial coordinator. Interested and
potentially eligible participants will be asked to contact the
trial coordinator directly. Pamphlets will also be available in
patient waiting rooms of participating hospital clinics and
community clinics. Similar information will be advertised
in local newspapers to enhance recruitment. The trial
coordinator will provide details about the study and answer
questions by phone. The coordinator will confirm eligibility
including age, duration of symptoms and self-report
walking ability. Walking ability will be assessed by the
participants’ response to the question “are you able to walk
continuously for 30 min without the use of aids or without
stopping to rest or stoop forward to alleviate your symp-
toms?” Self-reported walking ability has been shown to be
highly correlated (r = 0.80) to the self-paced walking test
(SPWT) [31]. The SPWT is a validated objective measure
of walking ability in LSS [31]. Only interested participants
who respond “NO” and meet the other inclusion/exclusion
criteria will be given an appointment for an intake
assessment at the study site (Mount Sinai Hospital in
Toronto Canada).
Inclusion and exclusion criteria
At the intake assessment, a licensed practitioner will assess
potential participants. The assessment will confirm eligibil-
ity (Table 1) and will include a history, physical examination
and a review of imaging results provided by the referring
specialist. Eligible and willing participants will be asked to
provide informed written consent. Consenting participants
Fig. 1 Study Flow Process of f assessment
Ammendolia et al. Chiropractic & Manual Therapies  (2016) 24:25 Page 3 of 10
will be asked to complete a baseline questionnaire, a short
physical performance battery (SPPB) [32] and perform a
30-min SPWT [31].
Randomization to treatment groups
Randomization will take place following the completion of
the consent process, baseline questionnaire, SPPB and the
SPWT (Table 2). All participants will be randomly allo-
cated to Group 1, the self-management training program
with instructional workbook, video and pedometer or
Group 2, a single instructional session and the instruc-
tional workbook, video and pedometer (Fig. 1). The
randomization sequence will be prepared by the study
biostatistician ahead of recruitment using a computerized
random numbers table [NQuery Advisor® 7.0 [33]]. The
biostatistician will provide the trial coordinator with se-
quentially numbered sealed opaque envelopes containing
the allocation for Group 1 or 2. The study biostatistician
will not be involved in the selection, treatment or follow-
up of participants.
Interventions and controls
Participants will be scheduled to begin either the self-
management training program (Group 1) or the single
instructional session (Group 2) based on their random
assignment.
Group 1: self management training program with
instructional workbook, video and pedometer
Participants randomly assigned to Group 1 will receive the
self management-training program with instructional
workbook, video and pedometer at the study centre. All
instruction and treatments will be provided by licensed
chiropractors. Participants will be scheduled for twelve, 15-
min sessions over a 6-week period (two treatment sessions
per week). Four weeks following the 6-week treatment
period a follow-up treatment (booster) session will be
scheduled. Participants will be scheduled as regular patients
at the Chiropractic Spine Clinic and Spinal Stenosis
Program at Mount Sinai Hospital. All appointments will be
confirmed 24 h in advance via telephone or e-mail as
preferred by the participant as per usual treatment protocol.
The intent is to provide participants with treatment that
simulates real practice in terms of scheduling, time spent
and content of treatment.
The Group 1 participants will receive the following:
Education: Participants will receive instruction
on self-management strategies using a cognitive
behavioural approach [29]. Treating practitioners
will provide information on the causes of pain and
disability due to LSS, its natural history and prognosis.
They will receive instruction on how to manage
symptoms and maintain daily routines using problem
solving, pacing, relaxation and body positioning
[29, 34]. Reassurance, positive re-enforcement, goal
setting and graded activity will be used to reduce pain
related fear and improve self-efficacy [29, 35] and to
improve function [36]. Participants will be instructed
on how to reduce the lumbar lordosis when standing
and walking using body repositioning techniques
(the pelvic tilt).
Exercises: Participants will receive instruction on
muscle stretching, strengthening and conditioning
exercises directed at improving overall back and
lower extremity fitness and facilitating lumbar flexion
[26, 37]. Tight muscles that promote lumbar extension
(quadriceps, hip flexors, iliopsoas and erector spinae)
will be progressively stretched and muscles that
Table 1 Inclusion and exclusion criteria
Inclusion criteria
1. Age greater or equal to 50 years
2. Clinical symptoms of back and/or radiating lower limb or buttock
pain; fatigue or loss of sensation in the lower limbs aggravated by
walking and/or standing and relieved by sitting.
3. Intermittent or persistent pain without progressive neurological
dysfunction
4. Duration of symptoms and signs for more than 3 months
5. Imaging confirmed spinal canal narrowing using MRI, CT scan,
myelography or ultrasound
6. Clinical signs and symptoms corresponding to segmental level of
narrowing identified by imaging
7. Patients with degenerative spondylolisthesis are included
8. Not considered to be a surgical candidate (in the next 12 months)
or patient unwilling to have surgery
9. Able to perform mild-moderate exercise
10. Able to walk without assistive devices for at least 20 m and less
than 30 min continuously
11. Able to give written informed consent and complete interviews
and questionnaires in English.
Exclusion criteria
1. Severe degenerative stenosis with intractable pain and progressive
neurological dysfunction
2. Lumbar spinal stenosis not caused by degeneration
3. Lumbar herniated disc diagnosed during the last 12 months
4. Previous back surgery for lumbar spinal stenosis or instability
5. Underlying spinal disorder such as ankylosing spondylitis,
neoplasm, infection or metabolic disease
6. Intermittent claudication due to vascular disease
7. Severe osteoarthrosis or arthritis of lower extremities causing
limited walking ability
8. Neurologic disease causing impaired function of the lower limbs,
including diabetes
9. Psychiatric disorders and/or cognitively impaired
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promote and control lumbar flexion will be
strengthened (upper and lower abdominals).
Exercise instruction will be provided and reviewed
at each session and will be part of a progressive
structured home exercise program. A graduated
walking and/or stationary cycling program to improve
lower extremity conditioning and overall fitness will
be part of the home exercise program [38]. A written
exercise and conditioning program schedule will be
provided to participants outlining the type, frequency
and intensity of the exercises to be performed. The
exercises are to be performed twice per day at home
with the number, intensity and frequency of each
exercise increasing each week for a period of 6 weeks.
Manual Therapy: The aim of the manual therapy will
be to improve the flexibility of the lumbar spine and
to facilitate lumbar inter-segmental flexion. At each
session, manual therapy will be directed to the lumbar
and thoracic spine, pelvis and lower extremities.
Specific techniques will include low amplitude high
velocity manipulation [26], joint, soft tissue, and neural
mobilization [26, 39–41], lumbar flexion-distraction
[27, 42], and manual muscle stretching [25]. The
specific combination of manual therapy techniques
used will be at the discretion of the treating practitioner
based on identified underlying functional impairments.
Education, exercise instruction and manual therapy will
be provided at each session and tailored to the needs of the
participant by the treating chiropractor. An instructional
workbook and video will be provided to all participants.
This workbook and video provide education and a step-by-
step guide on how to perform all the exercises and body re-
alignment techniques, and are aimed at reinforcing the in-
structions received during the training sessions. The
workbook also includes a diary to record exercise and self-
management activities during the study period. Participants
will also be provided a pedometer (Pedusa PE-771,
Pedometers USA) with instruction and asked to record
once per week the maximum number of continuous
walking steps and time (minutes) to stop walking due to
neurogenic symptoms.
Group 2: single instructional session with instructional
workbook, video and pedometer
Participants randomized to this group will receive the
instructional workbook, video and pedometer provided
and explained in a single 15–30 min session with a experi-
enced licensed chiropractor not involved in the provision
of the self-management training program. The emphasis
on the instructional session is on reviewing the material in
the workbook and the structure of the 6 week exercise
program. No manual therapy will be provided during the
session.
Data collection and follow-up
Table 2 summarizes the data to be collected during the
trial. We will follow-up with participants at 6 weeks, and 3,
6 and 12 months following randomization. A trained
blinded assessor will conduct all follow-up assessments at
the study site. Should patients be unable to attend a follow-
up in person, all self-report measures will be administered
via telephone. All assessors will receive training in order to
Table 2 Measures collected at baseline and follow-up periods
Measures Baseline 6 Weeks 3 Months 6 Months 12 Months
Socio-demographic characteristics x
Duration of symptoms (back or leg) x
Dominant pain (back or leg) x
Co-Morbidity Disease Index x
Self Paced Walking Test x x x x x
Zurich Claudication Questionnaire (ZCQ)
Symptom and Functional scales
x x x x x
Oswestry Disability index
(ODI) and ODI walk
x x x x x
Numerical rating scale for back pain x x x x x
Numerical rating scale for leg pain x x x x x
36-item short-form health survey (V2) x x x x x
Center for Epidemiological Studies-Depression
Scale (CES-D)
x x x x x
Short Physical Performance Battery (SPPB) x x x x x
Falls Efficacy Scale (FES) x x x x x
Co-interventions and compliance x x x x
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standardize assessments and minimize inter- and intra-
assessor variability. The assessors will be blinded to the
treatment allocation and will be responsible for all follow-
up assessment per assigned participant. The following out-
comes will be measured at each follow-up.
Outcomes
Primary outcome
Objective walking capacity Walking capacity will be
assessed using the SPWT. The test requires subjects to
walk on a level surface without support at their own
pace until forced to stop due to symptoms of LSS or a
time limit of 30 min [43]. Test termination will be
defined as a complete stop of 3 s. A blinded assessor will
follow one metre behind the subject, without conversing,
with a distance instrument (Lufkin Pro-Series Model
PSMW38), and stopwatch. Distance walked and time to
test termination will be recorded. The SPWT is consid-
ered the gold standard with high validity for assessing
walking capacity in this population since it directly
observes walking ability under conditions representative
of a real world setting [31, 44]. It has high test-retest
reliability (ICC = 0.98) [43]. The minimal clinically
important difference (MCID) in walking distance in this
population is unknown.
Secondary outcomes
Physical function This will be measured using the
physical performance scale of the Zurich Claudication
Questionnaire (ZCQ) also known as the Swiss Spinal
Stenosis Scale. The ZCQ is a validated condition-specific
measure consisting of three scales; a physical perform-
ance scale, a symptom severity scale and a patient
satisfaction scale [45, 46]. The physical performance
scale consists of five questions related to walking ability.
The mean un-weighted score will be calculated. The
scale has a high internal consistency with a Cronbach’s
coefficient of 0.91, a test-retest reliability correlation
coefficient of 0.82 and a responsiveness of 1.07 using the
standardized mean [45, 46]. The MCID has been
estimated to be 0.5 [45].
Symptom severity This will be measured using the
symptom severity scale of ZCQ. The symptom scale
consists of seven questions pertaining to overall severity
of pain, pain frequency, back pain and, pain in the leg,
numbness, weakness and balance disturbance. The scale
has a high internal consistency with a Cronbach’s coeffi-
cient of 0.87, a test-retest reliability correlation coefficient
of 0.92 and a responsiveness of 0.86 using the standard-
ized mean [45, 46]. The MCID is estimated to be 0.5 [45].
Functional disability Functional disability will be mea-
sured by the Oswestry Disability Index (ODI) [47]. The
ODI is a reliable and validated measure of back-related
disability where 0 represents no disability and 100 repre-
sent the worse possible disability. We will also record
separately the score of the walking section (ODI walk) of
the ODI. The ODI walk score has been shown to be
highly correlated to objective walking distance (r = 0.83).
The MCID for the ODI is 8–12 percentage points [48].
Leg and back pain intensity while walking Leg and
back pain intensity while walking will be independently
measured at baseline and at each follow-up with the 11-
point numerical rating scale (NRS). The NRS is a global
measure of pain intensity anchored by two extremes of
pain intensity ranging from 0 (referring to “No pain”) to
10 (referring to “Pain as bad as it could be”). The NRS has
good short-term test-retest reliability with correlation co-
efficients ranging from 0.95 to 0.99 when re-administered
within 24 h [49]. The NRS has good construct validity and
can distinguish between various levels of pain in subjects
with chronic post-operative pain [49, 50].
Health-related quality of life (H-RQoL) We will use
the Medical Outcomes Study Short-Form Health Survey
version two (SF-36) to measure health-related quality of
life. The SF-36 has 36 items that measure the H-RQoL
of a subject. Two summary scores can be computed: the
physical component score and the mental component
score. The questionnaire has been shown to have excel-
lent reliability demonstrated with internal consistency
and test-retest methods. The SF-36 is a valid and reliable
measure for clinical and general populations with a
reported intra-class correlation coefficient of 0.85 [51].
Co-morbidity scale We will use the validated and
reliable 18-item Co-Morbidity Disease Index that has an
emphasis on functional activity [52].
Depressive symptomatology Depressive symptomatol-
ogy in the previous week will be measured with the
Center for Epidemiological Studies-Depression Scale
(CES-D). The CES-D is a widely used 20-item self-
report scale designed to measure current level of depres-
sive symptomatology in population-based epidemiologic
research [53]. It has good test-retest reliability and
internal consistency and possesses good factorial and
discriminate validity [54]. The CES-D is scored from 0
to 60 with higher scores indicating greater depressive
symptomatology [53].
Lower extremity function and balance The Short
Physical Performance Battery (SPPB) will be used as an
objective assessment of lower extremity function and
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balance [32]. The SPPB is a collection of timed physical
tests including standing balance (tandem, semi-tandem,
side by side), 4-m walk and repeated sit-to-stand from a
chair. The examination requires 10–15 min to complete
on average. The overall score on the SPPB is strongly
correlated with current self-reported disability highly
predictive of future disability among community dwell-
ing older persons [32]. The individual physical tests
making up the SPPB have high inter-rater reliability
(kappa = 0.80–1.0) and summary scales have been shown
to have good to excellent test-retest reliability (kappa =
0.99) [32, 55]. The internal consistency of the summary
scale is adequate (Crochbach’s alpha = 0.76) [56].
Fear of falling Fear of falling is a significant predictor of
future falls and can be assessed using the Falls Efficacy
Scale (FES). The FES assesses patients’ perception of
balance and stability during usual activities of daily living
[57, 58]. The test-retest reliability is adequate within the
geriatric population (r = 0.71) and the instrument has
excellent internal consistency (Cronbach’s alpha = 0.91)
[57]. Furthermore, scores on the FES have been shown to
be moderately to highly correlated with other measures of
balance confidence (r = 0.55–0.86) [59].
Co-interventions We will measure co-interventions by
asking participants to self-report the type and frequency
of consultations with other health care providers and the
type of interventions received beyond those provided in
the trial. This would include physiotherapy, chiropractic,
massage therapy, acupuncture, epidural injections and
surgery. We will also ask participants if they have used
medications and the frequency of use for their back and/
or leg symptoms.
Compliance At each treatment visit and each follow-up
assessment, we will ask participants about their compliance
with their self-management programs (Groups 1 and 2).
We will ask how often they are performing their exercises,
body alignment techniques and self-management strategies.
We will also assess compliance from the weekly exercise
diary located in the instructional workbook.
Statistical Issues
Sample size
For the primary RCT we have estimated the sample size for
the primary outcome of objective walking capacity based
on an estimate of the difference in the proportion of partici-
pants who achieve a MCID in walking distance. Since the
MCID for the SPWT is unknown we will estimate it to be
an improvement in walking distance from baseline of 30 %
or more. We estimate a total of 30 % of participants will
achieve the estimated MCID in Group 2 and 60 % in Group
1. Based on an estimate of 30 % difference in proportions, a
power of 0.8, an alpha of 0.05 and an estimated drop-out
rate of 20 %, a minimum of 52 participants per group is
estimated to be required to achieve significance using a
two-tailed t-test for two independent proportions [60]. Our
primary end point will be the 6-month follow-up.
Statistical analysis
Baseline status of treatment groups will be compared
using two-tailed independent samples t tests, Chi squared
tests of independence, and Mann-Whitney U tests as indi-
cated. Our analyses will be based on the “intention to
treat” principle. Data will contain repeated measurements
of the main response variables.
We will analyze the primary outcome (SPWT) by
calculating the differences in proportions meeting the
MCID using Pearson Chi Squared test with 95 % confi-
dence intervals. To control for potential confounding
(sex, education, perceived health status, dominant leg or
back pain, and hospital), logistic regression models and
generalized estimation equation (GEE) methods will be
used [5]. These models will control for baseline differ-
ences not balanced by randomization. Dichotomous
secondary outcomes will be analyzed similarly.
For continuous secondary outcomes we will first com-
pute the group-specific mean, standard deviation and
median at each follow-up interval. Second, we will build
ordinary least-square (OLS) models using generalized esti-
mating equation to account for the autocorrelation
present in the outcomes [5]. Third, we will test whether
the group effects are constant throughout the follow-up
periods [5]. Fourth, we will test whether imbalances in the
distribution of the baseline covariates confound the group
effects. Covariates added to the crude linear model that
change any of group regression coefficients by 10 %
percent or more will be retained as confounders in the
adjusted models [61]. The group effects will be reported
as the mean differences and 95 % for each follow-up
interval.
Protection of human subjects and assessment of safety
Protection of human subjects
The Mount Sinai Hospital (MSH) Research Ethics Board
has approved the study protocol (certificate number
14-0020).
Adverse events
We will measure the presence of adverse events that
may be associated with each of the interventions. This
will take place following each visit for participants
enrolled in Group 1. For participants enrolled in Group
1 and 2, adverse events will be assessed at each follow-
up visit. We will define adverse events as an unintended
sign or symptom of the intervention. These include:
significant increase in back and/or lower extremity pain,
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numbness, tingling, tiredness or claudication and cauda
equine syndrome. We will compute the incidence (95 %
CI) of each adverse event listed above. The cumulative
number of visits will be used as the denominator. Any
adverse event that is life threatening or associated with
significant disability will be reported to the Mount Sinai
Hospital Ethics Review Board.
Discussion
We selected a pragmatic RCT design for our study to
reflect a more real world clinical setting. LSS is a varied
and multi-faceted condition and in practice, the
approach is to tailor care to the patient’s individual
needs and tolerances. Participants randomized to Group
1 will receive the standard approach provided at the
Spinal Stenosis Clinic at Mount Sinai Hospital; however
tailoring will be required with respect to the intensity
and type of exercise and manual therapy techniques
used, not unlike usual practice. We selected a RCT
design because it is the study design of choice when
comparing the effectiveness of interventions.
We considered the SPWT to be the appropriate primary
outcome measure to address our primary aim. The SPWT
is the current gold standard for measuring objective walk-
ing capacity in LSS as it assesses walking ability in a real
life setting [43]. We also included the functional scale of
the ZCQ which is a self-report measure of walking ability
that is highly correlated (r = 0.80) to the SPWT [31]. The
SPWT is logistically more challenging to perform because
of the need of a large walking area and added personnel,
time and expense of conducting the test, and added time,
expense and inconvenience for participants travelling to
the study site for follow-ups. This may result in a higher
dropout rate for follow-up assessments. To mitigate this
possibility of non-compliance to follow-up SPWTs we
included the self-report functional scale of the ZCQ that
can easily be assessed by phone. Moreover, we can com-
pare our findings to other studies using this self-report
outcome measure.
At our centre we have two long and wide hallways
connected by two shorter hallways forming a large rect-
angular area (140 m long) where participants easily can
perform the SPWT.
However, the SPWT has a ceiling effect in that the test
measures distance traveled for a maximum of a 30-min
period. For this reason we will only include participants
who are more severely impaired and cannot complete
the SPWT during the baseline assessment.
We have included a 1-month booster session following
the 6-week training program. This emulates our current
practice protocol at our Spinal Stenosis Clinic at Mount
Sinai Hospital. The rationale being that LSS is a chronic
condition and patients may benefit from periodic monitor-
ing of their self-management skills and abilities. Periodic
reassurance and positive reinforcement may also be of
benefit especially among patients with underlying psycho-
social barriers such as poor coping skills that accentuate
functional limitations. Periodic monitoring and coaching
may help to improve longer-term outcomes.
A leading cause of failure of RCTs is the lack of enroll-
ment of sufficient number of participants into the study.
We have enlisted a large referral source for potential
participants. LSS is a very common condition seen by
neurosurgeons and orthopedic spine surgeons, rheuma-
tologists, physiatrists, family physicians and chiroprac-
tors. If our enrollment is deemed slow, we will expand
our referral source to the University of Toronto vascular
surgeons who also see a large number of patients with
neurogenic claudication caused by LSS. We will also
advertise in local newspapers and seniors publications.
In addition, we will distribute pamphlets to be placed in-
patient waiting areas at participating hospital clinics and
in community clinics. Compliance to follow-ups may be
problematic and we plan to provide incentives in the
form of covering transportation costs up to $25 per day.
We anticipate that assessor blinding (to assigned inter-
vention) during follow-up assessments will be challenging.
We will implement strict rules preventing the communi-
cation, regarding participant allocation among partici-
pants, the research coordinator and blinded assessors.
Study design limitations include the lack of blinding of
both practitioners and patients and this can introduce bias.
The multi-modal and pragmatic nature of the design
prohibits the determination of the component(s) of the
intervention that may be responsible for potential improve-
ments. There is potential for participants to receive other
interventions during the intervention and between follow-
up periods, which may impact the results. We will compare
co-interventions receive between group and comment on
the potential impact they may have on the results.
There is a high risk of falls in the LSS population and
we need to ensure safety of participants while perform-
ing the SPWT. We will train assessors accompanying
participants during the SPWT and practice procedures
to reduce the risk of falls during the SPWT.
Participants randomized to the single instructional
session may not follow the provided instructions, or may
perform the exercises incorrectly leading to potential for
injury. We will incorporate a safety monitoring protocol
and provide participants the opportunity to contact us
in an effort to reduce the risk of harm to participants
randomized to this intervention.
LSS is a chronic arthritic condition whose prevalence,
personal and economic burden is growing exponentially
due to the aging population. The vast majority of individ-
uals with LSS receive non-surgical care however, what
constitutes effective non-surgical care is unknown. A multi-
modal approach with a focus on self-management strategies
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as outlined in this proposal may be a practical and effective
means to improve walking ability, functional status and
quality of life in this population.
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